1-Methyl-3-propylimidazolium iodide,
119171-18-5,
1-propyl-3-methylimidazolium iodide,
GEO-02617,
MFCD08276385,
1-propenyl-3-methylimidazolium iodide,
1-Methyl-3-n-propylimidazolium iodide,
ACMC-1C1FW,
DSSTox_CID_29063,
DSSTox_RID_83282,
DSSTox_GSID_49207,
KSC491C6T,
SCHEMBL180141,
CHEMBL3183306,
DTXSID3049207,
CTK3J1169,
KS-00000WRW,
IVCMUVGRRDWTDK-UHFFFAOYSA-M,
1-methyl-3-propylimidazoliumiodide,
EBD32995,
Tox21_202654,
ANW-17287,
AKOS015833273,
AKOS015898179,
RTR-003231,
TRA0038084,
1-N-Methyl-3-N-propylimidazolium iodide,
NCGC00260202-01,
1-methyl-3-propyl-imidazol-1-ium iodide,
AK176116,
AN-24799,
SY033839,
1-methyl-3-propyl imidazolium iodide salt,
AB1010983,
DB-061531,
TR-003231,
CAS-119171-18-5,
FT-0696613,
M1440,
MFCD08276385 (95%),
I11-0593,
Q-102677,
1-Methyl-3-propylimidazolium iodide, >=98.0% (HPLC),
17-N-tert-Butylcarboxamide androst-3,5-diene-3-carboxylic acid; (17b)-17-[[(1,1-Dimethylethyl)amino]carbonyl]-androsta-3,5-diene-3-carboxylic acid,
CYCLOBUTANONE,
1-Methyl-3-propylimidazolium iodide, 95% - 25G 25g,
1-Methyl-3-propylimidazolium iodide, 99% - 25G 25g,
1191-95-3,